fluoresceine serb
tradis gat ltd - fluorescein sodium - solution for injection - fluorescein sodium 10 g / 100 ml - fluorescein - fluorescein - for examination of the retina by fluorescent angiography.
fluorescein serb fluorescein sodium 500mg/5ml injection solution ampoule
clinect pty ltd - fluorescein sodium, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - fluorescein angiography of the fundus and of the iris vasculature. this medicinal product is for diagnostic use only.
fluoresceine serb
tradis gat ltd - fluorescein sodium - solution for injection - fluorescein sodium 10 g / 100 ml - fluorescein - for examination of the retina by fluorescent angiography.
fluorescein serb
clinect nz pty limited - fluorescein 100 mg/ml (as fluorescein sodium formed in process from fluorescein and sodium hydroxide); - solution for injection - 500 mg/5ml - active: fluorescein 100 mg/ml (as fluorescein sodium formed in process from fluorescein and sodium hydroxide) excipient: sodium hydroxide water for injection - fluorescein is indicated for angiography of the fundus and of the iris vasculature. this medicinal product is for diagnostic use only.
fluorescein 100 mg/ml solution for injection
pharmargus limited - fluorescein sodium - solution for injection - 100 milligram(s)/millilitre - fluorescein
fluoresceine 10 % faure inj. sol. i.v. amp.
serb sa-nv - fluorescein sodium 100 mg/ml - solution for injection - fluorescein sodium 100 mg/ml - fluorescein
fluorescein sodium sterop 1 g/5 ml inj. sol. i.v. amp.
laboratoires sterop sa-nv - fluorescein sodium 1 g/5 ml - solution for injection - 200 mg/ml - fluorescein sodium 200 mg/ml - fluorescein
fluorescein sodium and benoxinate hydrochloride solution/ drops
bausch & lomb incorporated - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product. risk summary there are no available data on the use of fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% should be given to a pregnant woman only if clearly needed. risk summary there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of fluorescein sodium and beno
fluorescein sodium and benoxinate hydrochloride solution/ drops
oceanside pharmaceuticals - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product. risk summary there are no available data on the use of fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% should be given to a pregnant woman only if clearly needed. risk summary there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of fluorescein sodium and beno
fluorescein sodium and benoxinate hydrochloride solution/ drops
bausch & lomb americas inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product. risk summary there are no available data on the use of fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% should be given to a pregnant woman only if clearly needed. risk summary there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of fluorescein sodium and beno